G F Skovsted1, L S Kruse, R Larsen, A F Pedersen, S Trautner, M Sheykhzade, L Edvinsson. 1. Department of Clinical Experimental Research, Glostrup Research Institute, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND AND PURPOSE: Endothelins act via two receptor subtypes, ETA and ETB . Under physiological conditions in coronary arteries, ETA receptors expressed in smooth muscle cells mediate vasoconstriction whereas ETB receptors mainly found in endothelial cells mediate vasorelaxation. However, under pathophysiological conditions, ETB receptors may also be expressed in vascular smooth muscle cells mediating vasoconstriction. Here, we have investigated whether vasoconstrictor ETB receptors are up-regulated in coronary arteries after experimental myocardial ischaemia in rats. EXPERIMENTAL APPROACH: Male Sprague-Dawley rats were subjected to either heart ischaemia-reperfusion (15 min ischaemia and 22 h reperfusion), permanent ischaemia (22 h) by ligation of the left anterior descending coronary artery, or sham operation. Using wire myography, the endothelin receptor subtypes mediating vasoconstriction were examined in isolated segments of the left anterior descending and the non-ligated septal coronary arteries. Endothelin receptor-mediated vasoconstriction was examined with cumulative administration of sarafotoxin 6c (ETB receptor agonist) and endothelin-1 (with or without ETA or ETB receptor blockade). The distribution of ETB receptors was localized with immunohistochemistry and quantified by Western blot. KEY RESULTS: Endothelin ETB receptor-mediated vasoconstriction and receptor protein levels were significantly augmented in coronary arteries situated downstream of the occlusion after ischaemia-reperfusion compared with non-ischaemic arteries. In contrast, the ETA receptor-mediated vasoconstriction was unaltered in all groups. CONCLUSIONS AND IMPLICATIONS: Ischaemia-reperfusion induced local up-regulation of ETB receptors in the smooth muscle cells of coronary arteries in the post-ischaemic area. In contrast, in non-ischaemic areas, ETB receptor function was unaltered.
BACKGROUND AND PURPOSE: Endothelins act via two receptor subtypes, ETA and ETB . Under physiological conditions in coronary arteries, ETA receptors expressed in smooth muscle cells mediate vasoconstriction whereas ETB receptors mainly found in endothelial cells mediate vasorelaxation. However, under pathophysiological conditions, ETB receptors may also be expressed in vascular smooth muscle cells mediating vasoconstriction. Here, we have investigated whether vasoconstrictor ETB receptors are up-regulated in coronary arteries after experimental myocardial ischaemia in rats. EXPERIMENTAL APPROACH: Male Sprague-Dawley rats were subjected to either heart ischaemia-reperfusion (15 min ischaemia and 22 h reperfusion), permanent ischaemia (22 h) by ligation of the left anterior descending coronary artery, or sham operation. Using wire myography, the endothelin receptor subtypes mediating vasoconstriction were examined in isolated segments of the left anterior descending and the non-ligated septal coronary arteries. Endothelin receptor-mediated vasoconstriction was examined with cumulative administration of sarafotoxin 6c (ETB receptor agonist) and endothelin-1 (with or without ETA or ETB receptor blockade). The distribution of ETB receptors was localized with immunohistochemistry and quantified by Western blot. KEY RESULTS: Endothelin ETB receptor-mediated vasoconstriction and receptor protein levels were significantly augmented in coronary arteries situated downstream of the occlusion after ischaemia-reperfusion compared with non-ischaemic arteries. In contrast, the ETA receptor-mediated vasoconstriction was unaltered in all groups. CONCLUSIONS AND IMPLICATIONS: Ischaemia-reperfusion induced local up-regulation of ETB receptors in the smooth muscle cells of coronary arteries in the post-ischaemic area. In contrast, in non-ischaemic areas, ETB receptor function was unaltered.
Authors: Daphne Merkus; Birgit Houweling; Anton H van den Meiracker; Frans Boomsma; Dirk J Duncker Journal: Am J Physiol Heart Circ Physiol Date: 2004-09-30 Impact factor: 4.733
Authors: Vincent J de Beer; Henri J D de Graaff; Maaike Hoekstra; Dirk J Duncker; Daphne Merkus Journal: Am J Physiol Heart Circ Physiol Date: 2010-03-26 Impact factor: 4.733
Authors: S Martínez-Revelles; L Caracuel; A Márquez-Martín; Ap Dantas; E Oliver; P D'Ocon; E Vila Journal: Br J Pharmacol Date: 2012-02 Impact factor: 8.739
Authors: Christopher Adlbrecht; Martin Andreas; Bassam Redwan; Klaus Distelmaier; Julia Mascherbauer; Alexandra Kaider; Michael Wolzt; Ioana-Alexandra Tilea; Thomas Neunteufl; Georg Delle-Karth; Gerald Maurer; Irene M Lang Journal: EuroIntervention Date: 2012-04 Impact factor: 6.534
Authors: Lodi C W Roksnoer; Richard van Veghel; René de Vries; Ingrid M Garrelds; Usha M Bhaggoe; Edith C H Friesema; Frank P J Leijten; Marko Poglitsch; Oliver Domenig; Marian C Clahsen-van Groningen; Ewout J Hoorn; A H Jan Danser; Wendy W Batenburg Journal: Kidney Int Date: 2015-04-01 Impact factor: 10.612
Authors: David J Durgan; Randy F Crossland; Eric E Lloyd; Sharon C Phillips; Robert M Bryan Journal: J Cereb Blood Flow Metab Date: 2014-11-26 Impact factor: 6.200
Authors: Maurits R Hollander; Guus A de Waard; Lara S F Konijnenberg; Rosalie M E Meijer-van Putten; Charissa E van den Brom; Nanne Paauw; Helga E de Vries; Peter M van de Ven; Jurjan Aman; Geerten P Van Nieuw-Amerongen; Peter L Hordijk; Hans W M Niessen; Anton J G Horrevoets; Niels Van Royen Journal: PLoS One Date: 2016-07-08 Impact factor: 3.240
Authors: Gry Freja Skovsted; Lars Schack Kruse; Lukas Adrian Berchtold; Anne-Sofie Grell; Karin Warfvinge; Lars Edvinsson Journal: PLoS One Date: 2017-03-21 Impact factor: 3.240
Authors: Carlos A Cañas; Santiago Castaño-Valencia; Fernando Castro-Herrera; Felipe Cañas; Gabriel J Tobón Journal: J Transl Autoimmun Date: 2020-12-14
Authors: Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire Journal: Pharmacol Rev Date: 2016-04 Impact factor: 25.468
Authors: Xu Meng; Ying Zhang; Kun-Qi Yang; Yan-Kun Yang; Xian-Liang Zhou Journal: Int J Environ Res Public Health Date: 2016-07-25 Impact factor: 3.390
Authors: M Lukács; K Warfvinge; L S Kruse; J Tajti; F Fülöp; J Toldi; L Vécsei; L Edvinsson Journal: J Headache Pain Date: 2016-07-05 Impact factor: 7.277